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Abstract 
Protein kinase GCN2 regulates translation in amino acid–starved cells by phosphorylating eIF2. GCN2 contains a 
regulatory domain related to histidyl-tRNA synthetase (HisRS) postulated to bind multiple deacylated tRNAs as a 
general sensor of starvation. In accordance with this model, GCN2 bound several deacylated tRNAs with similar 
affinities, and aminoacylation of tRNAPhe weakened its interaction with GCN2. Unexpectedly, the C-terminal 
ribosome binding segment of GCN2 (C-term) was required in addition to the HisRS domain for strong tRNA 
binding. A combined HisRS+C-term segment bound to the isolated protein kinase (PK) domain in vitro, and tRNA 
impeded this interaction. An activating mutation (GCN2c-E803V) that weakens PK–C-term association greatly 
enhanced tRNA binding by GCN2. These results provide strong evidence that tRNA stimulates the GCN2 kinase 
moiety by preventing an inhibitory interaction with the bipartite tRNA binding domain. 
Introduction 
Protein synthesis in eukaryotic cells is inhibited in response to starvation, stress, or viral infection (Clemens 
1996) by phosphorylation of translation initiation factor 2 (eIF2) on serine 51 of its α subunit. Phosphorylation of 
eIF2 converts it from a substrate to an inhibitor of the guanine nucleotide exchange factor eIF2B, decreasing 
formation of the ternary complex (eIF2–GTP–Met-tRNAiMet) that transfers Met-tRNAiMet to the ribosome. Four 
mammalian eIF2α kinases have been identified that are regulated by different stimuli: HRI (hemin deprivation), 
PKR (double-stranded RNA in virus-infected cells) (Clemens 1996), PEK or PERK (unfolded proteins in the ER) (24, 
9), and mouse GCN2 (serum starvation) (2, 26). There are also GCN2 homologs in N. crassa (Sattlegger et al. 
1998), D. melanogaster (19, 12), and S. cerevisiae, where this enzyme was first discovered. Thus, GCN2 may be 
the most widespread and founding member of the eIF2α kinase subfamily (Dever 1999). 
 
The activation of PKR or HRI in mammalian cells inhibits general protein synthesis (Clemens 1996). By contrast, 
activation of GCN2 in yeast cells stimulates translation of GCN4 mRNA, encoding a transcriptional activator of 
amino acid biosynthetic enzymes. Four short open reading frames (uORFs) in the GCN4 mRNA leader underlie a 
specialized reinitiation mechanism that elevates GCN4 translation in response to small decreases in ternary 
complex levels insufficient to impair general translation. Thus, eIF2α phosphorylation in amino acid–starved 
yeast cells induces specifically a transcriptional activator that can rectify amino acid limitation. Dominant 
activating alleles of GCN2 have been isolated that derepress GCN4 under nonstarvation conditions, and the most 
severe of these GCN2c mutations inhibit general translation and cell growth due to high levels of eIF2α 
phosphorylation (Hinnebusch 1996). 
 
It is thought that GCN2 is activated by uncharged tRNAs that accumulate in amino acid–starved cells partly 
because mutations in aminoacyl tRNA synthetases (aaRSs) lead to GCN2-dependent derepression of GCN4 
without any starvation for amino acids (Hinnebusch 1996). Additionally, GCN2 contains a region homologous to 
histidyl-tRNA synthetase (HisRS) located C-terminal to the kinase domain (Wek et al. 1989) (Figure 1A). 
Mutations in the GCN2 HisRS-like domain in conserved residues required for tRNA binding by authentic class II 
aaRSs (the m2 motif) inactivate GCN2 function in vivo. These mutations also impair GCN2 kinase activity in cell 
extracts and destroy binding of tRNA to the isolated HisRS domain (29, 30). As GCN4 translation is derepressed 
by starvation for any of several amino acids (29, 11), the HisRS domain of GCN2 presumably cannot distinguish 
between different tRNA species and only discriminates against aminoacylated tRNAs. This prediction has not 
been tested, however, and it is possible that GCN2 binds charged and uncharged tRNAs alike but is activated 
only by the latter. The HisRS domain is conserved in all known GCN2 orthologs, suggesting that activation by 
uncharged tRNA is an evolutionarily conserved feature of these enzymes. 
 Figure 1. The C-Term Is Required in Addition to the m2 Motif of the HisRS-Related Region for tRNA Binding by GCN2 
(A) The 1659 aa sequence of GCN2 is shown schematically with the following functional domains indicated: the 
binding domain for the GCN1–GCN20 complex, an uncharacterized pseudokinase domain (ΨPK), protein kinase 
domain (PK), HisRS-like region, and C-terminal ribosome binding and dimerization (RB/D) domains shown with 
shading or stippling. The flag at the N terminus designates the FLAG and polyhistidine tags incorporated into 
the protein for affinity purification. Above the schematic are listed the amino acid positions in GCN2 and 
locations of signature motifs (m1, m2, and m3) of class II aminoacyl-tRNA synthetases. The asterisk marks the 
methionine previously considered to be the first residue of GCN2 but now known to be residue 70. Arrows or 
hatched boxes above or below the schematic mark the locations of gcn2 mutations Y1119L,R1120L (m2), Δ1538–
1557 (ΔK3), K1552L, K1553I, K1556I (K3), Δ1536–1659 (ΔC), and cE803V. 
 
(B) Characterization of affinity-purified GCN2 proteins. (Left) Samples of purified FLAG-tagged wild-type (wt) or 
mutant proteins designated as in (A) were resolved by 8% SDS–PAGE and stained with Coomassie Brilliant Blue 
(lanes 2–13). For each protein, 0.4 and 0.8 μg were loaded in successive lanes indicated with brackets. Lane 1 
contains molecular weight markers. (Right) In lanes 14–18, 0.1 μg of the indicated proteins were resolved by 8% 
SDS–PAGE and subjected to immunoblot analysis using antibodies against GCN2 (HL2523). 
 
(C) The purified wild-type (lanes 2–4) or m2 mutant proteins (lanes 5–7) described in (B) were incubated at the 
indicated concentrations with 20 nM of [32P]-labeled total yeast tRNA in 20 μl of GMSA buffer (20 mM HEPES [pH 
7.45], 150 mM NaCl, 7.5 mM MgCl2, 10% glycerol, 0.2 U/μl Rnasin [Promega]). The GCN2–tRNA complexes were 
resolved by electrophoresis in a 6% polyacrylamide gel in 0.5 × Tris-borate-EDTA buffer (3 hr, 120V), dried under 
vacuum, and visualized by autoradiography (the GMSA). In lanes 8–13, GMSA assays were performed using the 
indicated wild-type or mutant purified proteins at 40 nM. 
 
(D) 2 μl of GCN2 antiserum (lane 3) or 2 μl of preimmune serum (lane 4) were added to a binding reaction 
containing 40 nM GCN2 and 20 nM [32P]tRNA and subjected to GMSA, as in (C). The sample in lane 1 contained no 
GCN2. (SS), supershifted complex. 
 
The extreme C-terminal segment of yeast GCN2 (C-term) is also essential for GCN2 function in vivo (Wek et al. 
1990). The C-term mediates ribosome binding in cell extracts (15, 31) and contains the principal dimerization 
determinants in GCN2 (Qiu et al. 1998) (Figure 1A). The isolated C-term can bind double-stranded RNA in vitro 
and interact with ribosomes in cell extracts, leading to the suggestion that it mediates ribosome binding by 
GCN2 through interactions with double-stranded segments of rRNA (Zhu and Wek 1998). We showed recently 
that the extreme N terminus of GCN2 functions as the binding domain for the GCN1–GCN20 regulatory complex, 
which promotes the activation of GCN2 by uncharged tRNA in vivo (Garcia-Barrio et al. 2000). 
 
In this report, we show that purified GCN2 interacts with multiple uncharged tRNAs with similar affinities but 
that it binds to aminoacylated tRNAPhe less tightly than to deacylated tRNAPhe. These results provide direct 
evidence for two key postulates of our model. We found unexpectedly that the C-term is required in addition to 
the HisRS domain for strong tRNA binding by GCN2 in vitro. Remarkably, the isolated PK domain formed a stable 
complex with a fragment containing the combined HisRS+C-term regions, and this interaction was impeded by 
uncharged tRNA. Consistently, the HisRS+C-term segment bound tRNA much more tightly than did full-length 
GCN2. Moreover, an activating GCN2c mutation that weakened association between the PK and C-term 
segments greatly enhanced tRNA binding by the full-length protein. These findings indicate a straightforward 
mechanism for activation of GCN2 by uncharged tRNA, wherein tRNA binding eliminates an inhibitory physical 
interaction between the PK and HisRS+C-term domains. 
Results 
GCN2 Binds Different Uncharged tRNAs with Similar Affinities but Discriminates against 
Charged tRNA 
To analyze the tRNA binding properties of GCN2 in vitro, we affinity-purified from yeast cells a tagged form of 
the protein (encoded by GCN2-FL) bearing the FLAG epitope and a polyhistidine stretch at the N terminus (Table 
1 and Figure 1B, [wt]). The two affinity tags did not interfere with GCN2 regulatory function in vivo (data not 
shown). The purified GCN2 was tested for binding to total yeast tRNA by the gel mobility shift assay (GMSA) 
using gel-purified total yeast tRNA 5′ end–labeled with 32P. As shown in Figure 1C, a discrete complex containing 
[32P]tRNA was formed in a dose-dependent manner with GCN2 (wt). Addition of GCN2 antibodies to the binding 
reaction led to a novel complex of reduced electrophoretic mobility (supershift), verifying that the complex 
contained GCN2 (Figure 1D). 
 
Table 1. Plasmids 
 
Plasmid Description Reference 
pDH103 GCN2-FL, FLAG-6 × His–tagged GCN2 ORF under yeast GAL promoter in 
pEMBLyex4 (Cesareni and Murray 1987); 2μ 
This study 
pDH104 GCN2-FL-Y1119L R1120L (gcn2-FL-m2) in pDH103 backbone This study 
pDH109 GCN2-FL-K628R in pDH103 backbone This study 
pDH110 GCN2-FL-Δ1536–1659 (gcn2-FL-ΔC) in pDH103 backbone This study 
pDH111 GCN2-FL-K1552L K1553I K1556I (gcn2-FL-K3) in pDH103 backbone This study 
pDH112 GCN2-FL-Δ1538–1557 (gcn2-FL-ΔK3) in pDH103 backbone This study 
pDH114 GCN2-FL-E803V (GCN2-FL-cE803V) in pDH103 backbone This study 
p245 HisRS+C-term (H+C), 6 × His–tagged GCN2 codons 999–1659 under , E. coli lac 
promoter 
(Wek et al. 
1995) 
p274 HisRS (H), 6 × His–tagged GCN2 codons 999–1536 under , E. coli lac promoter (Wek et al. 
1995) 
p297 HisRS-Y1119L,R1120L (H-m2) in p274 backbone (Wek et al. 
1995) 
p245-m2 HisRS+C-term-Y1119L,R1120L (H+C-m2) in p245 backbone This study 
p245-K3 HisRS+C-term-K1552L,K1553I,K1556I (H+C-K3) in p245 backbone This study 
p245-
ΔK3 
HisRS+C-term-Δ1538–1557 (H+C-ΔK3) in p245 backbone This study 
pHQ298 C-term (C), 6 × His–tagged GCN2 codons 1498–1659 under , E. coli lac promoter This study 
pHQ551 GST-PK, GST fusion to GCN2 codons 568–999 under , E. coli lac promoter (Qiu et al. 
1998) 
p331 eIF2α–ΔC, SUI2 codons 1–199 under , E. coli lac promoter (Zhu et al. 
1996) 
pHQ400 lexA-HA-GCN2, LexA-, HA-tagged GCN2 codons 27−1659 under yeast ADH1 
promoter, 2μ 
(Qiu et al. 
1998) 
p630 Wild-type GCN2, 2μ (Wek et al. 
1990) 
p2459 gcn2-605 (Zhu and Wek 1998) in p630 backbone This study 
pB91 gcn2-Δ1538–1557 in p630 backbone This study 
p2461 gcn2-Δ1536–1659 in p630 backbone (Qiu et al. 
1998) 
 
It was shown previously that the Y1119L and R1120L substitutions in the m2 motif of the HisRS-like domain 
impaired GCN2 function in vivo (the gcn2-m2 allele), and they abolished tRNA binding in a Northwestern assay 
by a recombinant polypeptide containing only the GCN2 HisRS-like domain (Wek et al. 1995). Accordingly, we 
purified the full-length GCN2 protein containing these mutations (the m2 mutant; Figure 1A and Figure 1B) and 
examined it for complex formation with total tRNA in the GMSA. As shown in Figure 1C, the m2 protein failed to 
bind tRNA at 4-fold higher concentrations than were required to observe binding by wild-type GCN2. Mixing 
together equal amounts of the wild-type and m2 mutant proteins did not diminish complex formation by wild-
type GCN2, ruling out the presence of an inhibitor in the mutant preparation (data not shown). We conclude 
that purified full-length GCN2 can form a specific complex with tRNA in a manner dependent on the m2 motif in 
the HisRS-like domain. 
 
To test our prediction that GCN2 can bind different tRNAs with similar affinities, we compared individual 
unlabeled tRNAs for their ability to compete with total [32P]tRNA for complex formation with GCN2. As shown in 
Figure 2C, addition of an ∼100-fold excess of unlabeled total tRNA essentially eliminated complex formation 
between GCN2 and total [32P]tRNA, whereas an equimolar amount of poly(A) RNA had no effect on the amount 
of GCN2–[32P]tRNA complex formed. Gel-purified yeast tRNAPhe and , E. coli tRNATyr, tRNALys, and tRNAVal each 
had competitor activity similar to that of total yeast tRNA (Figure 2A–2C). We also showed that each of these 
individual tRNAs, when end-labeled with 32P, formed similar amounts of complex with GCN2 at equivalent 
concentrations of tRNA and protein (data not shown). We conclude that GCN2 has similar binding affinities for 
various individual uncharged tRNAs. 
 Figure 2. GCN2 Binds Different Uncharged tRNAs with Similar Affinities and Discriminates between Acylated and Deacylated 
tRNAPhe 
(A) [32P]-labeled total yeast tRNA at 20 nM was incubated with purified GCN2 protein at 40 nM and either with no 
other tRNA (lane 2), with unlabeled yeast tRNAPhe at 40 nM, 160 nM, 640 nM, 1.28 μM, or 2.5 μM (lanes 3–7), or 
with unlabeled , E.coli tRNATyr (lanes 8–12) at the same concentrations used for tRNAPhe in lanes 3–7, and 
subjected to the GMSA. The sample in lane 1 contained no GCN2. 
 
(B and C) Reactions were carried out exactly as in (A) except using , E. coli tRNALys , E. coli tRNAVal, total tRNA, or 
poly(A) RNA as unlabeled competitors, at the same concentrations given above for yeast tRNAPhe. Lane 1 in (B) and 
lane 2 in (C) contained GCN2 but no competitor (−); lanes 12 and 1 in (B) and (C), respectively, contained no GCN2. 
 
(D) [32P]-labeled tRNAPhe at 40 nM and purified GCN2 at 120 nM were incubated with no other tRNA (lane 2, [–]), 
with 80 nM, 160 nM, or 240 nM of unlabeled tRNAPhe (lanes 3–5), with the same amounts of aminoacylated 
tRNAPhe (lanes 6–8), or with the same amounts of aminoacylated tRNAPhe deacylated prior to addition (lanes 9–11), 
and subjected to the GMSA. The sample in lane 1 contained no GCN2. Based on their relative abilities to compete 
with [32P]-labeled tRNAPhe for binding to GCN2 and the percentage of tRNAPhe that was aminoacylated, we estimate 
that uncharged tRNAPhe binds GCN2 ∼9-fold more tightly than does charged tRNAPhe. 
 
A second prediction of our model is that uncharged tRNA should bind more tightly than charged tRNA to GCN2. 
To test this prediction, purified yeast tRNAPhe was aminoacylated with phenylalanine and compared with 
uncharged tRNAPhe for competitor activity in the GMSA. Roughly 70% of the tRNAPhe was aminoacylated under 
the conditions of our assays (data not shown). As shown in Figure 2D, the partially aminoacylated tRNAPhe had 
substantially less competitor activity than did equivalent amounts of uncharged tRNAPhe. To ensure that the 
tRNAPhe was not damaged during aminoacylation, we deacylated the charged tRNAPhe by alkaline hydrolysis and 
found that it recovered competitor activity comparable to the starting uncharged tRNAPhe (Figure 2D). We 
conclude that aminoacylation of tRNAPhe decreased its affinity for GCN2, in accordance with our model. 
 
Lysine Residues in the C-Terminal Segment of GCN2 Are Required for Binding of 
Uncharged tRNA In Vitro 
The C-term domain of GCN2 is required for kinase function in vivo (28, 31), for ribosome binding (15, 31), and for 
dimerization of full-length GCN2 molecules in cell extracts (Qiu et al. 1998). The location of several GCN2c 
mutations in the C-term (Wek et al. 1990) suggested that this region also has a role in regulating kinase activity 
by uncharged tRNA. Accordingly, we asked whether a deletion that removes most of the C-term (Δ1536–1659; 
Figure 1A, [ΔC]) would alter the affinity of GCN2 for uncharged tRNA. We purified the product of gcn2-FL-ΔC 
(Figure 1B, [ΔC]) and found that it was completely defective for tRNA binding in the GMSA (Figure 1C, [ΔC]). 
 
It was reported that a recombinant GCN2 C-term segment (residues 1536–1659) can bind to yeast ribosomes 
and has poly(I)–poly(C) binding activity dependent on lysine residues at positions 1552, 1553, and 1556. 
Substitutions of these Lys residues in full-length GCN2 with Leu, Ile, and Ile (the gcn2–605 allele) impaired GCN2 
function in vivo and its association with ribosomes in cell extracts. Accordingly, it was proposed that these Lys 
residues mediate a critical interaction between the C-term and rRNA (Zhu and Wek 1998). Having uncovered a 
requirement for the C-term in binding tRNA by GCN2, we asked whether Lys residues 1552, 1553, and 1556 also 
contribute to this activity. Mutant FLAG-tagged proteins containing the aforementioned substitutions in the Lys 
residues (K3 mutant) or a small deletion of amino acids 1538–1557 encompassing the Lys residues (ΔK mutant) 
were purified (Figure 1A and Figure 1B) and tested for tRNA binding activity. Both the K3 and ΔK3 mutant 
proteins appeared to be completely defective for binding total [32P]tRNA in the GMSA (Figure 1C). We conclude 
that Lys residues 1552, 1553, and 1556 in the C-term are required for tRNA binding by full-length GCN2, in 
addition to their role in ribosome binding. 
 
To provide additional support for this last conclusion, we investigated the tRNA binding activities of recombinant 
fragments encompassing the GCN2 HisRS and C-term regions. Polypeptides bearing an N-terminal polyhistidine 
tag and either the HisRS and C-term regions combined (H+C), only the HisRS domain (H), or only the C-term (C) 
were expressed in , E. coli and purified by nickel-affinity chromatography. The resulting preparations contained 
largely full-length forms of each recombinant protein (data not shown). The H+C fragment formed a stable 
complex with total [32P]tRNA, whereas the m2 mutant derivative of this fragment (H+C-m2) was completely 
defective for tRNA binding (Figure 3A). Removal of the entire C-term from the H+C fragment also abolished tRNA 
binding, and the C-term alone had no binding activity (Figure 3A, fragment C). Introducing either the K3 or ΔK 
mutations into the H+C protein to remove Lys residues 1552, 1553, and 1556 reduced, but did not abolish, the 
tRNA binding activity of the H+C protein (Figure 3B; see legend). These results support the idea that these Lys 
residues in the C-term contribute to tRNA binding by GCN2. The residual binding activity of the H+C-K3 and H+C-
ΔK3 mutant proteins compared to the inactivity of the H fragment (Figure 3A and Figure 3B) could be explained 
by postulating an additional tRNA binding determinant in the C-term outside of the interval removed by the ΔK3 
mutation. Alternatively, the C-term may promote the tRNA binding activity of the HisRS domain by facilitating 
dimerization (Qiu et al. 1998) (see below). 
 Figure 3. The HisRS+C-Term Fragment Expressed in , E. coli Exhibits High-Affinity tRNA Binding Dependent on the C-Term 
(A) [32P]-labeled total yeast tRNA at 20 nM was incubated with 60 or 120 nM of the following polyhistidine-tagged 
GCN2 fragments purified from , E. coli and subjected to the GMSA: the H+C polypeptide containing the HisRS and C-
term domains (residues 999–1659) (lanes 2–3), a derivative of H+C bearing the m2 mutations described in Figure 
1 (HisRS+C-m2, lanes 4–5), the H polypeptide containing the HisRS-like region (residues 999–1536) (lanes 6–7), a 
derivative of H containing the m2 mutation (H-m2, lanes 8–9), and the C-term polypeptide (residues 1498–1659) 
(C, lanes 10–11). 
 
(B) [32P]-labeled total yeast tRNA at 20 nM was incubated with 12 or 24 nM of H+C or its derivatives containing the 
ΔK3 or K3 mutations described in Figure 1 and subjected to the GMSA. Quantification of the tRNA–protein 
complexes by phosphorimaging analysis indicated that the wild-type H+C fragment bound roughly twice as much 
tRNA as did equivalent amounts of the H+C-ΔK3 or H+C-K3 proteins. 
 
(C and D) [32P]-labeled total yeast tRNA at 1 nM was incubated with full-length GCN2 protein at 50 to 1000 nM ([C], 
lanes 2–5) or with the H+C polypeptide at 15 to 120 nM ([D], lanes 2–5). The percentages of total [32P]tRNA bound 
to the protein at each concentration were quantified by phosphorimaging, and the mean values from three 
replicate experiments had standard errors of <10%. The Kd value was equated with the protein concentration 
where 50% of the [32P]tRNA was bound to protein. 
Interestingly, we noted that the H+C fragment had a much greater affinity for tRNA than did full-length GCN2. 
Under conditions where the protein concentration was in large excess over the tRNA concentration, full-length 
GCN2 shifted the mobility of only ∼30% of the total [32P]tRNA at the highest protein concentrations we could 
achieve (1 μM) (Figure 3C), whereas the H+C fragment shifted ∼50% of the probe at a protein concentration of 
only 60 nM (Figure 3D). Thus, the apparent dissociation constant (Kd) of the H+C–tRNA complex is ∼60 nM, 
while the full-length GCN2–tRNA complex has an apparent Kd at least 20-fold larger. This difference in binding 
affinity may account for the fact that the ΔK3 mutation abolished tRNA binding by full-length GCN2 (Figure 1C) 
but only weakened tRNA binding by the H+C fragment (Figure 3B). 
 
The Lys Residues in the C-Term Are Required for Wild-Type Kinase Activity and 
Ribosome Association but Are Dispensable for Dimerization by GCN2 
The substitution mutations of Lys residues 1552, 1553, and 1556 impaired GCN2 function in vivo (Zhu and Wek 
1998), and the same was found for the ΔK mutation (Qiu et al. 1998). We assayed the kinase activities of the 
purified proteins bearing these mutations using [γ-32P]ATP and a recombinant form of eIF2α (Zhu et al. 1996) as 
substrates. As shown in Figure 4A (right panel), the m2 mutant protein had substantially reduced 
autophosphorylation and eIF2α kinase activities compared to wild-type GCN2, but it retained more activity than 
the mutant protein containing Arg in place of the invariant lysine in kinase subdomain II (K628R) (Wek et al. 
1989). Given that the m2 mutation impairs tRNA binding, the reduced kinase activity of the m2 mutant suggests 
that tRNA had activated the wild-type protein in yeast cells prior to harvesting or during its purification. This 
interpretation is consistent with our observation that purified GCN2 could not be activated further by adding 
uncharged tRNA to the kinase assays at concentrations where most of the protein should be in a complex with 
tRNA (data not shown). Similar findings were made previously for the gcn2-m2 and GCN2 products assayed in 
whole cell extracts (Zhu et al. 1996). 
 
Figure 4. Substitution of Lysines in the C-Term Impairs Kinase Activity but Not Dimerization by Full-Length GCN2 
(A) The purified GCN2 proteins (0.25 μg) designated as in Figure 1 were incubated with 3 μCi of [γ-32P]ATP (6000 
Ci/mmol, Amersham), 1 μg of recombinant eIF2α−ΔC purified from , E. coli, and 0.5 μg of bovine serum 
albumin in 20 μl of kinase assay buffer (20 mM Tris–HCl [pH 7.9], 50 mM NaCl, 10 mM MgCl2, 1 mM 
dithiothreitol, and 100 μM PMSF) for 15 min at 30°C. The samples were resolved by 8%–16% SDS–PAGE and 
stained with Coomassie blue (left), and the dried gel was subjected to autoradiography (right). Lanes 1 and 8 
contained eIF2α−ΔC but no GCN2. The positions of phosphorylated GCN2 (GCN2∼P) and phosphorylated 
eIF2α−ΔC (eIF2α∼P) are indicated. The leftmost lane in the stained gel contained size standards. 
 
(B) Coimmunoprecipitation assay of heterodimerization by GCN2 and lexA-GCN2 proteins in vivo. Extracts were 
prepared from transformants of gcn2Δ strain HQY132 bearing high-copy-number plasmid pHQ400 encoding LexA-
HA-GCN2 and a high-copy plasmid bearing either wild-type GCN2 (p630, wt), gcn2–605 (p2459, K3), gcn2-Δ1538–
1557 (pB91, ΔK3), or gcn2-Δ1536–1659 (p2461, ΔC), and aliquots with 50 μg of protein were incubated with 
Protein A agarose beads prebound with anti-HA antibody. The immune complexes were subjected to 
immunoblot analysis using anti-GCN2 antibodies. Lanes 1–4 contain 5 μg of the extracts used for 
immunoprecipitation (Input); lanes 5–8 contain samples of the pellet fractions corresponding to 25 μg of starting 
extract (Pellet); and lanes 9–12 contain samples of the supernatants corresponding to 5 μg of starting extract. 
 
(C) Ribosome binding analysis. Cell extracts were prepared in a buffer lacking Mg2+ and cyclohexamide (to 
dissociate polysomes and 80S ribosomes into 40S and 60S subunits) from transformants of gcn2Δ yeast strain 
H1149 harboring high-copy plasmid p630 (wt), p2459 (K3), or p2453 (bearing gcn2-K628R,Δ1538–1557; ΔK3). 
Extracts were fractionated by velocity sedimentation in sucrose gradients, and the fractions were collected, 
monitored for A260, and subjected to immunoblot analysis, using antibodies against the N terminus of GCN2. 
Fraction 1 is the top of the gradient. The first and last lanes (In) contain 1/50 of the starting extracts. Positions of 
free 40S and 60S subunits are indicated by bars at the top. 
The K3 and ΔK3 mutant proteins also had reduced kinase activities relative to wild-type GCN2, (Figure 4A), 
consistent with their impaired abilities to interact with tRNA. The ΔC mutant had lower kinase activity than did 
the m2 protein (Figure 4A), suggesting that it lacks a function besides tRNA binding required for kinase activity. 
As the ΔC mutation impairs both ribosome binding (Ramirez et al. 1991) and dimerization (Qiu et al. 1998) of 
GCN2, one or both of these activities could be critically required for GCN2 activation by uncharged tRNA in 
extracts. 
 
To explore further the basis for differences in kinase activity among the C-term mutants, we compared the 
ability of K3 , ΔK3, and ΔC proteins to dimerize in vivo with a lexA-/HA epitope–tagged form of GCN2. In 
agreement with our previous findings (Qiu et al. 1998), the ΔC mutation substantially impaired dimer formation 
of GCN2 with lexA-HA-GCN2 (Figure 4B). In contrast, the K3 and ΔK3 proteins dimerized like wild-type GCN2 with 
lexA-HA-GCN2 (Figure 4B). We have also shown that a GCN2 C-terminal segment containing residues 1498–1659 
can dimerize in the yeast two-hybrid assay (Qiu et al. 1998), and we verified that the K1552L, K1553I, K1556I 
triple substitution (K3 mutation) had no effect on this two-hybrid interaction (data not shown). Thus, it is 
unlikely that removing Lys residues K1552, 1553, and 1556 from the C-term impairs GCN2 function in vivo by 
reducing dimerization. 
 
It was shown previously that the triple Lys substitution in the C-term impaired binding of GCN2 to polysomes 
and 60S ribosomal subunits in cell extracts (Zhu and Wek 1998). Binding of GCN2 to separated 40S and 60S 
subunits can also be assayed when extracts are prepared in the absence of Mg+2 to dissociate the polysomes 
(Ramirez et al. 1991). Under the latter conditions, we observed a relatively small defect in ribosome binding by 
the K3 mutant protein (Figure 4C). In contrast, the ΔK3 deletion nearly eliminated binding of full-length GCN2 to 
isolated ribosomal subunits (Figure 4C). We suggest that there are more stringent requirements for the binding 
of GCN2 to polysomes versus separated ribosomal subunits, and that Lys residues K1552, 1553, and 1556 
comprise only a subset of the amino acids involved in ribosome binding. In this view, the ΔK3 mutation would 
eliminate a larger number of residues required for the interaction and abolish ribosome binding by GCN2 as 
measured in both assays. Despite the fact that the K3 mutation does not abolish ribosome binding, the 
deleterious effect of this mutation on kinase activity in vivo probably reflects a compound defect in ribosome 
association and tRNA binding by GCN2. 
 
Uncharged tRNA Antagonizes Binding of the HisRS+C-Term Domain to the PK Domain of 
GCN2 
The results in Figure 3C and Figure 3D suggested that full-length GCN2 binds uncharged tRNA much less tightly 
than does the H+C fragment. A possible explanation for this phenomenon was prompted by our previous finding 
that the PK domain can physically interact with the isolated HisRS or C-term domains of GCN2 (Qiu et al. 1998). 
Thus, the PK domain and tRNA might compete for association with the HisRS-like and C-term regions. To test this 
idea, we asked whether the complex formed between the H+C polypeptide and total [32P]tRNA could be 
dissociated by addition of a GST fusion to the PK domain. As shown in Figure 5A, addition of GST-PK at 16-fold 
molar excess over the H+C fragment greatly reduced the H+C–[32P]tRNA complex detected by GMSA, whereas 
the same amounts of GST alone had no effect on H+C–[32P]tRNA complex formation. As expected, GST-PK could 
not form a stable complex with [32P]tRNA (Figure 5A). 
 
Figure 5. The PK Domain Competes with tRNA for Association with the HisRS+C-Term Segment of GCN2 
(A) [32P]-labeled tRNA at 20 nM was incubated with the H+C polypeptide at 60 nM and either with no other protein 
(lane 2), with the indicated amounts of GST-PK fusion bearing GCN2 residues (568–999) (lane 3–7), or with GST 
alone (lanes 13–17) and subjected to the GMSA. In lanes 8–12, GST-PK was present but H+C was omitted. 
 
(B) GST-PK at 1.1 μM (lanes 2–9) or GST alone at 2 μM (lane 1) immobilized on glutathione-Sepharose beads was 
incubated with the H+C polypeptide at 1.2 μM (lanes 2–5) in the absence (lane 2) or presence of 30 μM, 60 μM, or 
120 μM total yeast tRNA (lanes 3–5, respectively) at 4°C for 1 hr. Lanes 6–9 were identical to lanes 2–5 except that 
1.2 μM H+C-m2 polypeptide replaced the H+C polypeptide. Lanes 10–11 and 12–13 were identical to lanes 4–5 
except that 60 μM or 120 μM of aminoacylated tRNAPhe (lanes 10–11; [+]) or the same concentrations of 
nonacylated tRNAPhe (lanes 12–13; [–]) replaced total tRNA. After extensive washing, the bound proteins were 
eluted by boiling in sample buffer and subjected to immunoblot analysis with antibodies against the 
polyhistidine tag (Santa Cruz) (top), then stripped and reprobed with anti-GST antibodies (Santa Cruz) (bottom). 
Numbers on the left indicate the mobilities of size standards with the indicated molecular weights in kDa. 
 
(C) The indicated purified GCN2 proteins were subjected to GMSA as in Figure 1C. 
To provide additional evidence that tRNA and PK compete for interaction with the H+C fragment, we asked 
whether total uncharged tRNA could impede GST-PK–H+C complex formation as assayed by precipitation on 
glutathione-Sepharose beads (GST pull-down). We found that GST-PK, but not GST alone, formed a stable 
complex with the H+C fragment in the absence of tRNA (Figure 5B). Addition of total tRNA at a 100-fold molar 
excess over the H+C fragment dissociated the GST-PK–H+C complex. The H+C-m2 fragment also formed a stable 
complex with GST-PK, but in this case, addition of excess tRNA led to only a slight reduction in GST-PK–H+C-m2 
complex formation (Figure 5B). This last finding supports the notion that motif 2–dependent binding of tRNA to 
the H+C fragment is responsible for dissociation of the GST-PK–H+C complex. Similarly, we found that the H+C-
K3 protein could form a stable complex with GST-PK that was relatively resistant to challenge with tRNA, 
showing only an ∼50% reduction in the amount of complex formed at the highest tRNA concentration tested 
(data not shown). Finally, we observed that purified tRNAPhe was comparable to total tRNA in the ability to 
dissociate the GST-PK–H+C protein complex, whereas aminoacylated Phe-tRNAPhe had little or no dissociating 
activity in this assay (Figure 5B). The results in Figure 5A and Figure 5B provide strong evidence that binding of 
uncharged tRNA to the H+C fragment weakens interaction of the latter with the PK domain. This finding leads us 
to suggest that tRNA binding will release the PK domain from inhibitory interactions with the HisRS or C-term 
segments in the context of full-length GCN2. 
 
In vivo evidence supporting this hypothesis emerged from our analysis of the GCN2c-E803V allele, bearing a 
point mutation in the PK domain (Figure 1A). This mutation elicits high-level eIF2α phosphorylation by GCN2 
under nonstarvation conditions, where uncharged tRNA is scarce (Ramirez et al. 1992). Interestingly, the cE803V 
substitution impaired physical interaction between the PK and C-term domains in yeast two-hybrid assays and in 
vitro binding assays (H. Q. and A. G. H., unpublished data). This last finding suggests that the E803V mutation 
activates GCN2 by decreasing association between the PK and C-term domains. Our model predicts that weaker 
interaction between the C-term and PK domains should enhance tRNA binding by decreasing competition 
between the tRNA and PK domains for binding to the HisRS+C-term domain. In agreement with this prediction, 
the purified GCN2-cE803V protein (Figure 1B) showed a much higher affinity for tRNA compared to wild-type 
GCN2 (Figure 5D). Using low concentrations of [32P]tRNA in the GMSA, we estimated the Kd for GCN2-cE803V at 
∼100 nM, more than 10-fold lower than that of wild-type GCN2 and only slightly higher than that of the 
recombinant H+C fragment. The enhanced affinity of GCN2c-E803V for uncharged tRNA provides a satisfying 
explanation for its ability to be activated in nonstarved yeast cells. 
Discussion 
GCN2 Preferentially Binds Uncharged tRNAs 
GCN2 becomes activated in response to starvation for any single amino acid by binding the uncharged cognate 
tRNAs that accumulate in starved cells. Direct involvement of the HisRS-like domain in binding uncharged tRNA 
was demonstrated previously, and mutational analysis of the m2 motif provided strong evidence that tRNA 
binding to this domain is required for GCN2 activation in starved cells (29, 30). Using highly purified preparations 
of full-length GCN2, we obtained biochemical evidence that the HisRS-like domain can bind different individual 
tRNAs with similar affinities, and that aminoacylation of tRNA reduces its affinity for GCN2. Thus, the ability of 
deacylated tRNAs to activate GCN2 may reside simply in their higher affinities, relative to the corresponding 
acylated forms, for the tRNA binding domain in GCN2. 
 
The affinity of wild-type GCN2 for uncharged tRNA is fairly similar to that of authentic , E. coli HisRS (Bovee et al. 
1999). Whereas aaRSs discriminate strongly against certain noncognate tRNAs at the binding step, in other cases 
noncognate and cognate tRNAs bind with similar affinities and discrimination occurs at the step of catalysis or 
product release (Schimmel and Soll 1979). Interestingly , E. coli HisRS binds tRNAHis only slightly stronger than it 
does tRNAPhe (Bovee et al. 1999); thus, GCN2 may resemble authentic HisRS in binding different uncharged 
tRNAs with similar affinities. To account for the reduced affinity of GCN2 for charged tRNA, we imagine that the 
segment of the HisRS-like region corresponding to the active site cavity does not contain a pocket that can 
accommodate an amino acid attached to the acceptor stem of the tRNA. In an authentic class II enzyme, the 
binding pocket for the amino acid contains residues that provide Van der Waals contacts, hydrogen bonds, or 
electrostatic interactions with the backbone and side chain of the amino acid (18, 1). Some of these residues are 
replaced with nonconserved amino acids in the HisRS-like domain of GCN2 (16, 1), perhaps accounting for its 
reduced interaction with charged versus uncharged tRNAPhe. 
 
The C-Terminal Ribosome Binding/Dimerization Domain of GCN2 Is Also Required for 
tRNA Binding 
We found unexpectedly that lysine residues 1552, 1553, and 1556 in the C-term are required for tRNA binding to 
the HisRS-like domain of GCN2. Substitutions of these residues abolished tRNA binding by full-length GCN2 and 
reduced the binding activity of the recombinant HisRS+C-term (H+C) fragment. Mutations in motif 2 had a more 
severe effect than did removal of the C-term Lys residues, abolishing tRNA binding by both the H+C polypeptide 
and full-length GCN2. However, a recombinant polypeptide containing the HisRS-like domain alone (the H 
fragment) could not form a stable complex with tRNA, demonstrating an absolute requirement for the C-term in 
tRNA binding. 
 
The greater tRNA binding activity of the H+C fragment lacking only the three Lys residues (H+C-K3) versus the H 
fragment alone could reflect the presence of additional tRNA binding determinants in the C-term. Alternatively, 
the C-term may enhance tRNA binding by promoting dimerization of the HisRS region, as it contains a 
dimerization interface and also binds to the HisRS region (Qiu et al. 1998). This last explanation might account 
for the fact that the H polypeptide was shown previously to bind tRNA in the Northwestern assay (Wek et al. 
1995). Perhaps when the H fragment is concentrated by gel electrophoresis and tethered to a filter, dimerization 
of the HisRS-like segment can occur independently of the C-term and permit a reduced level of tRNA binding 
similar to that observed for the H+C-K3 and H+C-ΔK3 fragments lacking the C-term Lys residues. 
 
Mutating Lys residues 1552, 1553, and 1556 did not impair dimerization by the isolated C-term or by full-length 
GCN2. Thus, the reductions in tRNA binding and GCN2 kinase activity associated with these particular C-term 
mutations probably did not arise from reduced dimerization. Wek and colleagues showed that the C-term 
lysines are required for binding of full-length GCN2 to polysomes (Zhu and Wek 1998). We found that 
substitutions in the C-term lysines impaired but did not abolish ribosome binding, leading us to suggest that the 
strong requirement for these residues for GCN2 function in vivo additionally reflects their contribution to tRNA 
binding. Accordingly, we propose that the HisRS and adjacent C-term regions comprise a bipartite tRNA binding 
domain, and that the C-term has an additional function in ribosome binding. In class II aminoacyl-tRNA 
synthetases, the acceptor stem of the tRNA interacts with motif 2 (Ruff et al. 1991). It is tempting to propose 
that the C-term of GCN2 provides additional contacts with the anticodon stem in the manner proposed for 
authentic HisRS (1, 29) (Figure 6). In this view, eliminating contacts with the acceptor stem by mutating motif 2 
residues or with the anticodon stem by mutating the C-term lysines each would destabilize the GCN2–tRNA 
complex. 
 Figure 6. Model for Activation of GCN2: Dissociation of Autoinhibitory tRNA Binding Domain from the Kinase Domain 
Triggered by Binding of Uncharged tRNA 
 
Domains of GCN2 are labeled as follows: GCN1–GCN20 binding domain at the N terminus (N), pseudokinase domain (Ψ), 
protein kinase domain (PK), HisRS-like region (HisRS), and C-term (C). Both the inactive (left) and activated forms of wild-
type GCN2 are depicted as dimers because the tRNA binding (HisRS) domain is dispensable for dimerization; thus, it is 
unlikely that dimerization is triggered by the uncharged tRNA that builds up in starved cells. Dimerization is driven primarily 
by the C-term segment, but also occurs in the PK domain. The C-term and HisRS segments are responsible for autoinhibitory 
interactions with the kinase domain (depicted by double-headed arrows). For wild-type (wt) GCN2, binding of uncharged 
tRNA to the HisRS region and C-term segments triggers a conformational change that disrupts the inhibitory PK–C-term 
and PK–HisRS interactions (right) to permit phosphorylation of the substrate eIF2. The GCN2c-E803V protein binds tRNA and 
is activated under nonstarvation conditions where uncharged tRNA is scarce (left) because the E803V mutation weakens 
the PK–C-term interaction, reducing the ability of the PK domain to compete with tRNA for binding to the HisRS+C-term 
domains. 
 
tRNA and the Kinase Domain Compete for Association with the HisRS+C-Term Domain 
We previously detected physical interactions between the kinase domain of GCN2 and both the HisRS-like and C-
term segments by two-hybrid and in vitro binding assays (Qiu et al. 1998). Given that these three segments 
harbor all of the known GCN2c regulatory mutations (28, 16), we speculated that binding of the HisRS or C-term 
domains to the PK moiety could underlie the negative regulation of kinase activity in nonstarved cells. These 
negative interactions would be overcome through binding of uncharged tRNA to the HisRS-like domain in 
starved cells (Qiu et al. 1998). Here, we obtained direct evidence supporting this hypothesis by showing that 
tRNA can dissociate the complex formed between a GST-PK fusion and the H+C polypeptide. Thus, tRNA and the 
PK domain may compete for certain binding sites in the HisRS+C-term domain. This possibility is consistent with 
our finding that full-length GCN2 had a much lower affinity for tRNA than did the H+C polypeptide, as the 
presence of the PK domain in native GCN2 would be expected to antagonize its interaction with tRNA. Based on 
these findings, we propose that the combined HisRS+C-term region is bound to the kinase domain in nonstarved 
cells, where uncharged tRNA is scarce, and that these protein–protein interactions contribute substantially to 
the inhibition of kinase activity under these conditions. The higher concentration of uncharged tRNA in starved 
cells would favor tRNA binding to the HisRS+C-term, eliminating inhibitory contacts of the latter with the kinase 
domain and thereby activating GCN2 (Figure 6). 
 
Strong in vivo evidence supporting this model was provided by our finding that the GCN2c-E803V protein had a 
much greater affinity for tRNA than did wild-type GCN2. The cE803V mutation in the PK domain leads to 
activation of GCN2 under nonstarvation conditions (Ramirez et al. 1992), and this substitution impairs physical 
association of the PK and C-term domains (H. Q. and A. G. H., unpublished data). If the PK domain and tRNA 
compete for binding to the HisRS+C-term, then by weakening the association between PK and C-term the cE803V 
mutation should enhance tRNA binding by GCN2, as we observed. The increased affinity of purified GCN2c-
E803V for uncharged tRNA can account for its activation in nonstarved yeast cells when uncharged tRNA is 
scarce. Our observations that the cE803V mutation weakens PK–C-term interactions, enhances tRNA binding in 
vitro, and leads to constitutive activation of GCN2 in vivo provide a compelling combination of genetic and 
biochemical evidence supporting our model for GCN2 activation. 
 
We have argued previously that uncharged tRNAs bound to the decoding (A) site of the ribosome and base-
paired with their cognate codons in mRNA activate GCN2 (Ramirez et al. 1991). A similar mechanism operates in 
the stringent response of , E. coli where the ppGpp synthetase relA is activated by uncharged tRNAs in the A site 
(Cashel and Rudd 1987). It is intriguing that the C-term of GCN2 promotes both ribosome association 
(presumably via rRNA binding) and tRNA binding, but it is presently unclear whether these interactions are 
mutually exclusive. If the contacts between GCN2 and rRNA must be severed to accommodate binding of tRNA, 
this would lead to dissociation of the activated GCN2–tRNA complex from the ribosome. While ribosome binding 
by GCN2 would be required for interaction with uncharged tRNA in the A site, its subsequent release from the 
ribosome may enhance the ability to bind and phosphorylate eIF2. 
Experimental Procedures 
Plasmids and Strains 
The plasmids employed are described in Table 1. Details of their construction will be provided on request. Yeast 
strains GP3299 (Pavitt et al. 1997), HQY132 (Qiu et al. 1998), and H1149 (Wek et al. 1990) were described 
previously. 
 
Protein Purification 
Transformants of strain GP3299 (a ura3–52 leu2–3 leu2–112 GCD2-K627T gcn2Δ) bearing plasmids pDH103, 
pDH104, pDH109, pDH110, pDH111, pDH112, or pDH114 (Table 1) were grown to saturation in SC-Ura medium, 
diluted to OD600 = 0.4 in minimal medium containing 10% galactose as carbon source and minimal supplements, 
and grown to OD600 ∼0.9, whereupon 10 mM 3-AT was added. At OD600 of ∼2.5, cells were harvested (∼25 g) 
and washed with cold distilled water containing EDTA-free protease inhibitor cocktail (PIC) (Boehringer 
Mannheim) and 0.5 mM PMSF, resuspended in ice-cold binding buffer (BB) (100 mM sodium phosphate [pH 
7.4], 500 mM NaCl, 0.1% Triton X-100, EDTA-free PIC, 1 μg/ml leupeptin, and 1 mM PMSF), and disrupted with a 
French Press. Lysates were clarified by centrifugation at 39,000 × g for 2 hr at 4°C and mixed with 1 ml of M2-
FLAG affinity resin (Sigma) for ∼4 hr at 4°C. The resin was washed three times with 10 vol of BB and eluted with 
3 vol of 2 mM FLAG peptide in BB, followed by two more volumes of the same. The eluates were pooled and 
concentrated with an Amicon Centricon filter (exclusion limit of Mr 10,000). For nickel affinity purification, 100 μl 
of Ni-NTA Agarose (Qiagen) was washed twice with 500 μl of BB containing 5 mM imidazole for 30 min and 
mixed with FLAG-affinity-purified GCN2 at 4°C for 1 hr, washed three times with 500 μl of BB containing 30 mM 
imidazole, and eluted twice with 200 μl of BB containing 250 mM imidazole. The eluates were concentrated as 
above, dialyzed against 100 mM sodium phosphate (pH 7.4), 100 mM NaCl, and stored at −800 C in 100 mM 
sodium phosphate (pH 7.4), 50% (v/v) glycerol. The polyhistidine-tagged GCN2 fragments (Wek et al. 1995), GST 
and GST-PK fusion proteins (Qiu et al. 1998), and the eIF2α−ΔC (Zhu et al. 1996) protein were purified from , E. 
coli as previously described. 
 
Gel Mobility Shift Assays of GCN2–tRNA Complexes 
Total yeast tRNA was purchased from Roche, purified individual tRNAs were purchased from Sigma, and poly(A) 
RNA was obtained from Pharmacia. All of the tRNAs were gel purified as described previously (Seong and 
RajBhandary 1987). The tRNAs were 5′ end–labeled by dephosphorylating with calf intestine alkaline 
phosphatase (New England BioLabs) and then phosphorylated with [γ-32P]ATP and polynucleotide kinase. The 
GMSA was conducted essentially as described previously (Simos et al. 1996). The [32P]tRNA–GCN2 complexes 
were quantified with a phosphorimager (Molecular Dynamics) using the Image Quant software provided by the 
vendor. For the supershift assay, GCN2 antiserum (HL2523) (Garcia-Barrio et al. 2000) or preimmune antiserum 
was purified with Avid-Almatrix (Unisyn Technologies) according to the vendor's instructions, and 2 μl were 
added to the binding reactions prior to electrophoresis. 
 
Aminoacylation of Yeast tRNAPhe 
Aminoacylation was carried out at 37°C for 30 min in a reaction mixture containing 100 mM Tris–HCl (pH 7.4), 12 
mM ATP, 40 mM MgCl2, 2 μM amino acid mixture minus Phe (Sigma), 0.2 μM L-[2,3,4,5,6-3H]Phe (122 Ci/mmol; 
Amersham), 1.8 μM Phe, 0.25 μM purified tRNAPhe, and a 40 μl/ml crude preparation of rabbit aminoacyl-tRNA 
synthetases (Hatfield et al. 1979). The Phe-tRNAPhe was extracted with an equal volume of extraction buffer (10 
mM sodium acetate [pH 4.5], 10 mM MgCl2, 1 mM EDTA, and 450 mM NaCl) and water-saturated phenol, 
ethanol precipitated, and resuspended in 1 ml of buffer F (100 mM sodium acetate [pH 5.0], 1 mM 
dithiothreitol). The tRNAs were desalted on a G-25 column equilibrated with 0.1 mM potassium cacodylate (pH 
5.5) at 4°C, lyophilized, resuspended in buffer F, and stored at −80°C. Scintillation counting of the final 
preparation indicated that a minimum of 70% of the tRNAPhe was aminoacylated. Deacylation of the Phe-tRNAPhe 
was carried out by adding Tris–HCl (pH 9.0) to 1.8 M and incubating at 30°C for 30 min, during which >95% of the 
charged tRNA was deacylated, as monitored by filter binding assays and scintillation counting. The deacylated 
tRNA was ethanol precipitated and resuspended in H2O at the same concentration as the starting sample of 
acylated tRNAPhe. 
 
Analysis of Dimerization and Ribosome Binding by GCN2 In Vivo 
Assays for the presence of heterodimers containing GCN2 and lexA-GCN2 proteins by coimmunoprecipitation 
analysis (Qiu et al. 1998) and of polysome binding by GCN2 (Ramirez et al. 1991) in yeast cell extracts were 
conducted as previously described. 
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